Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.20
Delayed Data
As of Apr 21
 -0.03 / -1.35%
Today’s Change
1.98
Today|||52-Week Range
4.33
-13.73%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Leamon Christopher P
Vice President-Research
Sale12/30/201623,244$2.55$59.3K-13.73%
Leamon Christopher P
Vice President-Research
Buy12/30/201626,178$2.10$55.0K-13.73%
Ellis P Ron
Sale6/24/201613,528$3.68$49.8K-33.13%
Low Philip S
Chief Scientific Officer
Buy5/10/201611,375$3.52$40.0K-37.32%
Low Philip S
Chief Scientific Officer
Buy11/15/201615,706$2.10$33.0K-25.17%
Brauer Keith E
Director
Buy7/27/201610,471$1.91$20.0K-31.25%
Sherman Michael A
President, Chief Executive & Financial Officer
Sale2/04/20173,092$2.18$6.7K+0.92%
Low Philip S
Chief Scientific Officer
Sale2/04/20171,888$2.18$4.1K+0.92%
Leamon Christopher P
Vice President-Research
Sale2/04/20171,888$2.18$4.1K+0.92%
Brinkley Michael A
Vice President-Quality
Sale2/04/20171,079$2.18$2.4K+0.92%
Page of 4